标题
Exploiting Herpes Simplex Virus Entry for Novel Therapeutics
作者
关键词
-
出版物
Viruses-Basel
Volume 5, Issue 6, Pages 1447-1465
出版商
MDPI AG
发表日期
2013-06-10
DOI
10.3390/v5061447
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Research Highlights: Highlights from the latest articles in nanomedicine
- (2013) Rekha Rani Sehgal et al. Nanomedicine
- Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection
- (2012) Thessicar E. Antoine et al. ANTIVIRAL RESEARCH
- Surface-modified protein nanospheres as potential antiviral agents
- (2012) Dana Baram-Pinto et al. CHEMICAL COMMUNICATIONS
- In vitro antiviral activity of dermaseptin S4and derivatives from amphibian skin against herpes simplex virus type 2
- (2012) Ines Bergaoui et al. JOURNAL OF MEDICAL VIROLOGY
- Aptamer That Binds to the gD Protein of Herpes Simplex Virus 1 and Efficiently Inhibits Viral Entry
- (2012) S. C. B. Gopinath et al. JOURNAL OF VIROLOGY
- Tin Oxide Nanowires Suppress Herpes Simplex Virus-1 Entry and Cell-to-Cell Membrane Fusion
- (2012) James Trigilio et al. PLoS One
- Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)
- (2011) Ian McGowan et al. AIDS
- Inhibition of Herpes Simplex Virus Type 1 and Type 2 Infections by Peptide-Derivatized Dendrimers
- (2011) Anna Luganini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ocular Distribution, Spectrum of Activity, andIn VivoViral Neutralization of a Fully Humanized Anti-Herpes Simplex Virus IgG Fab Fragment following Topical Application
- (2011) Marianne Berdugo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Marine organisms as a therapeutic source against herpes simplex virus infection
- (2011) Thanh-Sang Vo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Generation of neutralizing aptamers against herpes simplex virus type 2: potential components of multivalent microbicides
- (2011) M. D. Moore et al. JOURNAL OF GENERAL VIROLOGY
- Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
- (2011) Raymund R. Razonable MAYO CLINIC PROCEEDINGS
- Fusing structure and function: a structural view of the herpesvirus entry machinery
- (2011) Sarah A. Connolly et al. NATURE REVIEWS MICROBIOLOGY
- Herpes simplex virus infects most cell types in vitro: clues to its success
- (2011) Ghadah A Karasneh et al. Virology Journal
- Development of aptamer therapeutics
- (2010) David HJ Bunka et al. CURRENT OPINION IN PHARMACOLOGY
- Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
- (2010) Anupa R. Menjoge et al. DRUG DISCOVERY TODAY
- Topicaln-docosanol for management of recurrent herpes labialis
- (2010) Nathaniel S Treister et al. EXPERT OPINION ON PHARMACOTHERAPY
- Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases
- (2010) Michael D. Moore et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry
- (2010) V. Tiwari et al. JOURNAL OF GENERAL VIROLOGY
- Reevaluating Herpes Simplex Virus Hemifusion
- (2010) J. O. Jackson et al. JOURNAL OF VIROLOGY
- Herpes Simplex Virus Glycoproteins H/L Bind to Cells Independently of V 3 Integrin and Inhibit Virus Entry, and Their Constitutive Expression Restricts Infection
- (2010) T. Gianni et al. JOURNAL OF VIROLOGY
- Cascade of Events Governing Cell-Cell Fusion Induced by Herpes Simplex Virus Glycoproteins gD, gH/gL, and gB
- (2010) D. Atanasiu et al. JOURNAL OF VIROLOGY
- Bimolecular Complementation Defines Functional Regions of Herpes Simplex Virus gB That Are Involved with gH/gL as a Necessary Step Leading to Cell Fusion
- (2010) D. Atanasiu et al. JOURNAL OF VIROLOGY
- V 3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2
- (2010) T. Gianni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study
- (2010) John OʼLoughlin et al. SEXUALLY TRANSMITTED DISEASES
- Inhibition of HSV-1 Attachment, Entry, and Cell-to-Cell Spread by Functionalized Multivalent Gold Nanoparticles
- (2010) Dana Baram-Pinto et al. Small
- A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion
- (2009) Vaibhav Tiwari et al. ANTIVIRAL RESEARCH
- A role for heparan sulfate in viral surfing
- (2009) Myung-Jin Oh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Randomized Controlled Trial of the Safety of Candidate Microbicide SPL7013 Gel When Applied to the Penis
- (2009) Marcus Y Chen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Herpes Simplex Virus gD Forms Distinct Complexes with Fusion Executors gB and gH/gL in Part through the C-terminal Profusion Domain
- (2009) Tatiana Gianni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cross Talk among the Glycoproteins Involved in Herpes Simplex Virus Entry and Fusion: the Interaction between gB and gH/gL Does Not Necessarily Require gD
- (2009) E. Avitabile et al. JOURNAL OF VIROLOGY
- Insertion Mutations in Herpes Simplex Virus 1 Glycoprotein H Reduce Cell Surface Expression, Slow the Rate of Cell Fusion, or Abrogate Functions in Cell Fusion and Viral Entry
- (2009) J. O. Jackson et al. JOURNAL OF VIROLOGY
- Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide
- (2008) D. Pinna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The dermaseptin superfamily: A gene-based combinatorial library of antimicrobial peptides
- (2008) Pierre Nicolas et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Entry of herpesviruses into mammalian cells
- (2008) E. E. Heldwein et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A consistent nomenclature of antimicrobial peptides isolated from frogs of the subfamily Phyllomedusinae
- (2008) Mohamed Amiche et al. PEPTIDES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started